Sua, Helen B.
HRN: 23-70-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/12/2023
09/18/2023
IV
600mg
Q6
Cap Mr Tc Abscess Left Lower Lobe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes